These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25285548)

  • 1. N-of-1 (single-patient) trials for statin-related myalgia.
    Joy TR; Zou GY; Mahon JL
    Ann Intern Med; 2014 Oct; 161(7):531-2. PubMed ID: 25285548
    [No Abstract]   [Full Text] [Related]  

  • 2. N-of-1 (single-patient) trials for statin-related myalgia.
    Akinboro O; Williams L; Pomerantz D
    Ann Intern Med; 2014 Oct; 161(7):531. PubMed ID: 25285547
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.
    Ann Intern Med; 2014 Mar; 160(5):I-34. PubMed ID: 24737270
    [No Abstract]   [Full Text] [Related]  

  • 4. N-of-1 (single-patient) trials for statin-related myalgia.
    Joy TR; Monjed A; Zou GY; Hegele RA; McDonald CG; Mahon JL
    Ann Intern Med; 2014 Mar; 160(5):301-10. PubMed ID: 24737272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report.
    de Jong HJ; Meyboom RH; Helle MJ; Klungel OH; Niskanen L; Cohen Tervaert JW
    Ann Intern Med; 2014 Oct; 161(8):614-5. PubMed ID: 25329212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].
    Saku K; Zhang B; Noda K
    Nihon Naika Gakkai Zasshi; 2011 Dec; 100(12):3679-86. PubMed ID: 22338904
    [No Abstract]   [Full Text] [Related]  

  • 7. Statin, the black box.
    Hatem S; Boccara F
    Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
    [No Abstract]   [Full Text] [Related]  

  • 8. Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?
    Ikewaki K; Ayaori M
    Circ J; 2011; 75(6):1326-7. PubMed ID: 21532174
    [No Abstract]   [Full Text] [Related]  

  • 9. New light on statin side effects. What recent research on the cholesterol drugs means to you.
    Heart Advis; 2005 Aug; 8(8):3. PubMed ID: 16193557
    [No Abstract]   [Full Text] [Related]  

  • 10. Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes.
    Mori Y; Kuriyama G; Tanaka T; Tajima N
    Endocrine; 2009 Dec; 36(3):412-8. PubMed ID: 19834827
    [No Abstract]   [Full Text] [Related]  

  • 11. Discontinuation of statin therapy due to muscular side effects: a survey in real life.
    Rosenbaum D; Dallongeville J; Sabouret P; Bruckert E
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):871-5. PubMed ID: 22748604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
    Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F;
    Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statin therapy and muscle disorders].
    Abel T; Fehér J
    Orv Hetil; 2009 Feb; 150(6):261-3. PubMed ID: 19179258
    [No Abstract]   [Full Text] [Related]  

  • 14. Atorvastatin for stroke prevention.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect?
    Singh S; Nautiyal A; Dolan JG
    JOP; 2004 Nov; 5(6):502-4. PubMed ID: 15536291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
    Wlodarczyk J; Sullivan D; Smith M
    Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia.
    Mazza F; Stefanutti C; Di Giacomo S; Vivenzio A; Fraone N; Mazzarella B; Bucci A
    Am J Cardiovasc Drugs; 2008; 8(4):265-70. PubMed ID: 18690760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How safe is aggressive statin therapy?
    Guthrie RM
    Prog Cardiovasc Nurs; 2006; 21(3):140-5. PubMed ID: 16957460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
    Schwartz GG; Bolognese MA; Tremblay BP; Caplan R; Hutchinson H; Raza A; Cressman M
    Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.